GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of switched from compounded to brand and the titration reset itself — 19 comments in the full submission. View in context.
127
c/compounding·submitted 21 days ago by u/receptor_bias_rick

switched from compounded to brand and the titration reset itself

Pricingbranch of 6 comments

switched from compounded to brand and the titration reset itself. I have gone back and forth on this for months. Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot. Nothing in this thread is medical advice, and the choice between arrangements is…

Read the full submission and all 19 comments →

This branch

6 comments, started 21 days ago
u/marit_laurent16 points·21 days ago

A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.

replysharereportpermalink
u/lift_heavy_thingsresistance training23 points·20 days ago

Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.

replysharereportpermalink
u/receptor_bias_rickOP0 points·20 days ago

Is the compound still on the shortage list where you are?

replysharereportpermalink
u/kavya_kravchenko1 point·19 days ago

a 503B has to register and report, so there is a paper trail to ask for

replysharereportpermalink
u/marit_mwangi1 point·19 days ago

Agreed on potency testing of the finished preparation. That is a different question from the purity of the starting material.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →